• 3-M syndrome is a growth disorder presenting with severe pre-and postnatal growth retardation and is caused by mutations in 3 genes (CUL7, OBSL1, and CCDC8).
Introduction
3-M syndrome (MIM 273750, 612921, and 614205) was first recognized by Miller et al. [1] in 1975, who described a rare autosomal recessive primordial dwarfism characterized by severe pre-and postnatal growth retardation but with normal mental development. Approximately 100 cases have been reported in the literature since 1975 [2] . Children are characteristically born extremely small for gestational age and achieve a final height 5-6 SDS below the mean. Clinical characteristics include distinctive facial dysmorphism such as a triangular face, frontal bossing, mid-facial hypoplasia, fleshy tipped nose, and full fleshy lips. Characteristic radiological findings include slender long bones with diaphyseal constriction and flared metaphyses, tall vertebral bodies, anterior wedging of thoracic vertebral bodies, irregular upper and lower endplates, thoracic kyphoscoliosis, spina bifida occulta, small pelvic bones, small iliac wings, broad thorax with slender and horizontal ribs, and slightly delayed bone age. Prominent heels are most easily recognized in affected younger children. While the gonadal status of female patients with 3-M syndrome appears to be normal, male patients can develop gonadal failure with small testicular volumes, elevated gonadotropin concentrations, and sub-or infertility [3, 4] . From an endocrine perspective, serum growth hormone concentrations are usually normal and IGF-I concentrations are normal or low, while response to growth hormone therapy is variable but typically poor [5] .
3-M syndrome is a genetically heterogeneous condition with 3 causal genes currently identified. In 2005, autozygosity mapping revealed a 3-M syndrome locus on chromosome 6p21.1, and pathogenic mutations in Cullin 7 (CUL7 [MIM609577]) were subsequently identified as the primary cause of 3-M syndrome [6] . A previous study showed that mutations in CUL7 account for approximately 84% of cases of 3-M syndrome (52/62) [7] . Cullin 7 is a major structural component of E3 ubiquitin ligase, which is involved in the proteasomal degradation pathway targeting p53 and the IGF-1/insulin signalling molecule IRS-1 [8] . In 2009, mutations in Obscurin-like 1 (OBSL1 [MIM 610991]) were found as the second most common cause of 3-M syndrome [9] . OBSL1 encodes a cytoskeletal adaptor protein which has been shown to physically interact with CUL7, and loss-of-function mutations in OBSL1 lead to decreased levels of CUL7 [9] . A third 3-M causal gene was identified in 2011, in which 6 patients from 5 families carried truncating mutations in CCDC8, 4 of whom carried the same frameshift mutation p.K205EfsX59 [10] . In co-expression studies, CCDC8 was shown to directly interact with OBSL1 but not CUL7 [10] . However, similar to CUL7, CCDC8 acts as a co-factor for p53-induced apoptotic processes [8] . To date, there has only been 1 additional report of a single family with a mutation in CCDC8 [11] , and thus, the full clinical spectrum of patients with mutations in this gene is yet to be elucidated.
There are a multitude of genetic causes of short stature [12] , many of which can be difficult to diagnose due to the subtlety of the associated clinical features. Next generation sequencing provides the opportunity to rapidly assess many genes and even the entire exome, facilitating the diagnosis of rare genetic conditions [13] . Herein, we report a case of 2 sisters who lacked an obvious syndromic cause for their relatively mild short stature, and, via exome sequencing, were found to carry the previously reported homozygous p.K205EfsX59 mutation in CCDC8. These patients have the mildest degree of short stature associated with 3-M syndrome to date and demonstrate the power of exome sequencing in the diagnosis of children with short stature.
Case Report
Subject 1 Subject 1 was born at 37 weeks' gestation with a pregnancy complicated by intrauterine growth restriction, with a birthweight of 2.72 kg (-1.4 SDS). Her antenatal and postnatal course was otherwise unremarkable, and she was completely weaned from breastfeeding at 1 year of age. Her growth remained below the 3rd percentile throughout childhood (Fig. 1a) . Further investigations performed indicated a normal karyotype, coeliac screen, thyroid function tests, plasma amino acids, immunoglobulins, and faecal elastase. Her appetite appeared normal throughout this period, and there were no developmental concerns.
The subject is of Pakistani descent. Family history was significant for parental consanguinity. Her maternal great-grandfather and paternal grandfather were brothers. Her younger sister was also referred to the paediatric endocrinology team for concerns regarding her growth, but she has 2 older brothers of normal Mutation in CCDC8 Mild Short Stature height (188 and 175 cm). Her father is 180 cm and her mother 170 cm, giving her a mid-parental target height of 168 cm (75th-90th percentile).
Examination revealed proportionate short stature, mild clinodactyly, mild frontal bossing, and depression of her nasal bridge. After the molecular diagnosis was made via exome sequencing (see below), a closer examination indicated a triangular face, exaggerated lumbar lordosis, upturned nares, fleshy nose and lips, and prominent heels, which, although mild in presentation, could, together with her skeletal survey findings and family history, be suggestive of 3-M syndrome. IGF-1 and IGFBP-3 concentrations were normal: 119 ng/ml (-0.8 SDS, normal range 49-283) and 2.3 mg/L (-0.6 SDS, normal range 1.0-4.7), respectively. Height velocity remained normal throughout childhood. A skeletal survey revealed gracile long bones and ribs, pectus excavatum, and spina bifida occulta with a vertebral ossification defect in L4-5 but normal vertebral height (Fig. 2) .
At the age of 11 years, subject 1 started puberty with Tanner stage 2 breast development. A glucagon stimulation test was performed at this point due to her slightly suboptimal height velocity of 4.2 cm/year, but this revealed a normal growth hormone peak of 15.2 ng/mL and a normal cortisol peak of 1,070 nmol/L. The rest of her pituitary function screen was normal: free T 4 
Subject 2
Subject 2, the younger sister of subject 1, was born at 36 weeks' gestation with a pregnancy complicated by intrauterine growth restriction, with a birthweight of 2.27 kg (-2.6 SDS). She was noted to feed poorly and exhibited poor weight gain, only reaching 6.6 kg (-4.9 SDS) at 1.3 years of life when she was referred to paediatric endocrinology. Early clinical examination revealed frontal bossing and mid-facial hypoplasia. Investigations indicated a normal karyotype, coeliac screen, and thyroid function tests. IGF-1 and IGFBP-3 concentrations were normal: 111 ng/mL (-1.0 SDS, normal range 51-303) and 2.6 mg/L (+0.3 SDS, normal range 0.8-3.9), respectively. Height velocity remained normal throughout childhood (Fig. 1b) .
Further examination performed at 5.7 years of age revealed similar features to her sister, with upturned nares, fleshy nose and lips, long palpebral fissures, and prominent heels. Repeat endocrine biochemistry was performed at 9.1 years due to a deceleration in height velocity but these investigations were all normal: IGF-1 concentrations 111 ng/mL (-1.7 SDS, normal range 88-452), IGFBP-3 concentrations 3. 
Molecular Analysis
Ethical approval for the protocol was granted by the Cincinnati Children's Hospital Medical Center Institutional Review Board. Written informed consent was obtained from the subjects and their parents. Both subjects underwent whole exome sequencing at Cincinnati Children's Hospital Medical Center using previously described methods [14] . Given the known consanguinity and 2 affected siblings with unaffected parents, we hypothesized that the causal variant would be a rare homozygous non-synonymous variant present in both subjects. We excluded all variants present with a minor allele frequency greater than 0.001 in the 1,000 Genomes database (www.1000genomes.org), the Exome Aggregation Consortium browser (http://exac.broadinstitute.org), or our internal variant database. Only a single variant met these criteria, the homozygous p.K205EfsX59 mutation in CCDC8. We then confirmed this mutation via Sanger sequencing (Fig. 3) . PCR primers are available on request.
Discussion
To date, there have only been 2 reports describing a total of 9 patients in 6 families carrying CCDC8 mutations causing 3-M syndrome, and only 3 mutations were identified [10, 11] . The typical description of 3-M syndrome includes severe prenatal (usual birth weight SD scores <-3 SD) and postnatal growth retardation (adult height in the range of -8 to -4 SD), although the birth weight can fall within the lower part of the normal range [8] . Interestingly, patients with mutations in CCDC8 (i.e., 3-M syndrome type 3, MIM 614205) tend to have a milder phenotype with a mean height at presentation of -4.4 SD ( Table 1) . In this report, we describe 2 patients with a previously described homozygous frameshift mutation in CCDC8 who present with a considerably milder phenotype than previously described (Table 1) . Their current height SDS scores of -2.2 and -2.7 fall within the relatively mild-moderate short stature range and, notably, subject 1 had a normal birth weight, thus lacking prenatal growth retardation. Unfortunately, birth length data were unavailable for these patients so it is possible that subject 1 was small for gestational age based on length criteria. Notably, their parents were rather tall with a mid-parental target height of +1 SD; thus, their actual degree of growth failure is more significant when this is taken into account. This highlights the importance in considering the deviation from target height when assessing a patient's degree of short stature. Both subjects had normal head circumferences as is observed in 3-M syndrome. In retrospect, both subjects do exhibit mild features seen in 3-M syndrome including a slightly exaggerated lumbar lordosis, pectus excavatum, and hypermobile finger joints, but these are relatively non-specific and did not raise suspicion for this rare diagnosis. The fleshy heels, a distinct finding in 3-M syndrome, became less prominent with time. Similarly, the radiological features were quite subtle and were not fully appreciated until after the molecular diagnosis was obtained.
It is interesting to note that both subjects had elevated peak growth hormone and normal cortisol concentrations during a glucagon stimulation test. Additionally, they had normal IGF-1 levels. Taken together, the relatively robust growth hormone levels with normal IGF-1 levels may suggest a degree of growth hormone and possibly IGF-1 resistance, as has been previously described in 3-M syndrome [5] . In other cases reported in the literature, 2 patients with 3-M syndrome have been shown to have complete or partial growth hormone deficiency, although the majority have a normal growth hormone axis on testing [5, [15] [16] [17] . The rest of their pituitary function (TSH, LH, FSH, and PRL) screening was normal.
These 2 girls are older than the CCDC8-deficient patients reported in the previous study, and the elder sister has started puberty with no evidence of gonadal failure. Gonadal status of female patients with 3-M syndrome has previously been reported to be normal, while males may have hypergonadotropic hypogonadism. It is not clear whether mutations in CCDC8 affect gonadal status or if this is only the case in individuals with CUL7 mutations. Further follow-up of these patients is needed.
In conclusion, we report a case of 2 siblings carrying a previously reported homozygous frameshift mutation in CCDC8 with mild short stature, one of whom had a normal birth weight, thus representing the mildest presentation of 3-M syndrome to date. An explanation for the same mutation causing highly variable clinical presentations remains to be fully elucidated, although it is important to consider the distance from the mid-parental target height when quantifying the degree of growth failure. 3-M syndrome should be considered in children with mild skeletal abnormalities, normal/high growth hormone-IGF axis parameters and normal intelligence. We highlight the power of exome sequencing in children with short stature, which provides comprehensive genetic evaluation for patients who lack obvious specific molecular aetiologies.
